Lilly(Eli) & Co

NYSE:LLY  
230.04
-1.00 (-0.43%)
4:00:00 PM EDT: $229.97 -0.07 (-0.03%)
Strategic Combinations, Other Pre-Announcement

Lilly And Lycia Therapeutics Enter Into Strategic Collaboration To Discover And Develop Novel Lysosomal Targeting Chimera Degraders

Published: 08/25/2021 11:06 GMT
Lilly(Eli) & Co (LLY) - Lilly and Lycia Therapeutics Enter Into Strategic Collaboration to Discover and Develop Novel Lysosomal Targeting Chimera (lytac) Degraders.
Eli Lilly - Lycia Will Receive an Upfront Payment of $35 Million.
Eli Lilly - Lycia is Also Eligible to Receive Over $1.6 Billion in Potential Milestone Payments.
Eli Lilly - This Transaction Will Be Reflected in Lilly's Reported Results & Financial Guidance According to Generally Accepted Accounting Principles.
Eli Lilly - There Will Be No Change to Lilly's 2021 Non-GAAP Earnings per Share Guidance As a Result of This Transaction.